BCDA
Price
$2.35
Change
-$0.00 (-0.00%)
Updated
Nov 13 closing price
KPTI
Price
$0.87
Change
-$0.00 (-0.00%)
Updated
Nov 13 closing price
105 days until earnings call
Ad is loading...

BCDA vs KPTI

Header iconBCDA vs KPTI Comparison
Open Charts BCDA vs KPTIBanner chart's image
BioCardia
Price$2.35
Change-$0.00 (-0.00%)
Volume$56.89K
CapitalizationN/A
Karyopharm Therapeutics
Price$0.87
Change-$0.00 (-0.00%)
Volume$511.92K
CapitalizationN/A
BCDA vs KPTI Comparison Chart
Loading...
BCDA
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
KPTI
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
BCDA vs. KPTI commentary
Nov 15, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BCDA is a StrongSell and KPTI is a Sell.

COMPARISON
Comparison
Nov 15, 2024
Stock price -- (BCDA: $2.35 vs. KPTI: $0.87)
Brand notoriety: BCDA and KPTI are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BCDA: 45% vs. KPTI: 61%
Market capitalization -- BCDA: $8.23M vs. KPTI: $108.55M
BCDA [@Biotechnology] is valued at $8.23M. KPTI’s [@Biotechnology] market capitalization is $108.55M. The market cap for tickers in the [@Biotechnology] industry ranges from $473.6B to $0. The average market capitalization across the [@Biotechnology] industry is $2.76B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BCDA’s FA Score shows that 0 FA rating(s) are green whileKPTI’s FA Score has 1 green FA rating(s).

  • BCDA’s FA Score: 0 green, 5 red.
  • KPTI’s FA Score: 1 green, 4 red.
According to our system of comparison, KPTI is a better buy in the long-term than BCDA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BCDA’s TA Score shows that 4 TA indicator(s) are bullish while KPTI’s TA Score has 4 bullish TA indicator(s).

  • BCDA’s TA Score: 4 bullish, 4 bearish.
  • KPTI’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, both BCDA and KPTI are a good buy in the short-term.

Price Growth

BCDA (@Biotechnology) experienced а -2.08% price change this week, while KPTI (@Biotechnology) price change was -2.30% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.83%. For the same industry, the average monthly price growth was +3.51%, and the average quarterly price growth was +6.16%.

Reported Earning Dates

BCDA is expected to report earnings on Aug 13, 2024.

KPTI is expected to report earnings on Feb 27, 2025.

Industries' Descriptions

@Biotechnology (-1.83% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
KPTI($105M) has a higher market cap than BCDA($7.06M). KPTI YTD gains are higher at: 0.139 vs. BCDA (-76.413). BCDA has higher annual earnings (EBITDA): -8.53M vs. KPTI (-62.19M). KPTI has more cash in the bank: 152M vs. BCDA (1.42M). BCDA has less debt than KPTI: BCDA (1.14M) vs KPTI (196M). KPTI has higher revenues than BCDA: KPTI (146M) vs BCDA (428K).
BCDAKPTIBCDA / KPTI
Capitalization7.06M105M7%
EBITDA-8.53M-62.19M14%
Gain YTD-76.4130.139-55,083%
P/E RatioN/AN/A-
Revenue428K146M0%
Total Cash1.42M152M1%
Total Debt1.14M196M1%
FUNDAMENTALS RATINGS
BCDA vs KPTI: Fundamental Ratings
BCDA
KPTI
OUTLOOK RATING
1..100
6882
VALUATION
overvalued / fair valued / undervalued
1..100
55
Fair valued
4
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
100100
PRICE GROWTH RATING
1..100
8752
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
65n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

KPTI's Valuation (4) in the Biotechnology industry is somewhat better than the same rating for BCDA (55) in the null industry. This means that KPTI’s stock grew somewhat faster than BCDA’s over the last 12 months.

KPTI's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as BCDA (100) in the null industry. This means that KPTI’s stock grew similarly to BCDA’s over the last 12 months.

KPTI's SMR Rating (100) in the Biotechnology industry is in the same range as BCDA (100) in the null industry. This means that KPTI’s stock grew similarly to BCDA’s over the last 12 months.

KPTI's Price Growth Rating (52) in the Biotechnology industry is somewhat better than the same rating for BCDA (87) in the null industry. This means that KPTI’s stock grew somewhat faster than BCDA’s over the last 12 months.

KPTI's P/E Growth Rating (100) in the Biotechnology industry is in the same range as BCDA (100) in the null industry. This means that KPTI’s stock grew similarly to BCDA’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BCDAKPTI
RSI
ODDS (%)
N/A
Bearish Trend 2 days ago
75%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
77%
Bullish Trend 2 days ago
86%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
90%
MACD
ODDS (%)
Bullish Trend 2 days ago
79%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
88%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
88%
Bullish Trend 2 days ago
78%
Advances
ODDS (%)
Bullish Trend 3 days ago
77%
Bullish Trend 18 days ago
82%
Declines
ODDS (%)
Bearish Trend 7 days ago
88%
Bearish Trend 2 days ago
86%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
80%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
86%
Bullish Trend 2 days ago
70%
View a ticker or compare two or three
Ad is loading...
BCDA
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
KPTI
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SMWB11.120.42
+3.93%
Similarweb Ltd
PSTV1.310.02
+1.55%
Plus Therapeutics
TAYD44.900.52
+1.17%
Taylor Devices
ICFI167.34-1.15
-0.68%
ICF International
RBA91.16-1.71
-1.84%
RB Global

BCDA and

Correlation & Price change

A.I.dvisor indicates that over the last year, BCDA has been closely correlated with SMMT. These tickers have moved in lockstep 68% of the time. This A.I.-generated data suggests there is a high statistical probability that if BCDA jumps, then SMMT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BCDA
1D Price
Change %
BCDA100%
-2.08%
SMMT - BCDA
68%
Closely correlated
-6.21%
MDGL - BCDA
29%
Poorly correlated
-7.05%
INO - BCDA
28%
Poorly correlated
-3.69%
KOD - BCDA
28%
Poorly correlated
+8.27%
KPTI - BCDA
28%
Poorly correlated
-3.52%
More

KPTI and

Correlation & Price change

A.I.dvisor indicates that over the last year, KPTI has been loosely correlated with FDMT. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if KPTI jumps, then FDMT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KPTI
1D Price
Change %
KPTI100%
-3.52%
FDMT - KPTI
39%
Loosely correlated
-2.16%
NTLA - KPTI
38%
Loosely correlated
-3.24%
ALLO - KPTI
38%
Loosely correlated
-3.87%
LCTX - KPTI
36%
Loosely correlated
-3.77%
ARRY - KPTI
35%
Loosely correlated
+1.97%
More